ବ୍ରେନ୍ ଟ୍ୟୁମର୍ (ଗ୍ଲିଓମା)

High grade gliomas, particularly glioblastoma, are among the most aggressive brain tumors and are associated with poor outcomes despite standard treatment. Many patients, especially older adults or those with poor general health, are not suitable for surgery and have a life expectancy of less than 12 months. Current standard includes a shortened course of radiotherapy (over 3 weeks) combined with chemotherapy using temozolomide (TMZ), which offers limited survival benefits. This study aims to explore whether delivering radiotherapy in a shorter duration (1 or 2 weeks) at a higher dose, guided …

ସ୍ପୋନ୍ସର: ଟାଟା ମେମୋରିଆଲ୍ ସେଣ୍ଟର
ClinicalTrials.gov ରେ NCT07338539
ରେଜିଷ୍ଟ୍ରିରେ ଶେଷ ଅପଡେଟ୍ 18 ମେ 2026 · ଆମ ଦ୍ୱାରା ପଢାଯାଇଛି 20 ଅକ୍ଟୋବର 2026